TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland Carcinoma

This publication has 48 references indexed in Scilit:

• Biological therapy of salivary duct carcinoma
  The Journal of Laryngology & Otology, 2008
• Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab‐based therapy
  Head & Neck, 2007
• Oncogenic rearrangements of the NTRK1/NGF receptor
  Cancer Letters, 2005
• Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression
  Oncogene, 2005
• Detection of Overexpressed and Phosphorylated Wild-Type Kit Receptor in Surgical Specimens of Small Cell Lung Cancer
  Clinical Cancer Research, 2004
• RE: GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS; CLINICAL DEVELOPMENT AND POTENTIAL FOR PROSTATE CANCER THERAPY
  Journal of Urology, 2004
• Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor β Tyrosine Kinase Receptors in Synovial Sarcoma
  Clinical Cancer Research, 2004
• Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
  Nature, 2003
• Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: Expression patterns and effects onIn vitro invasive behavior
  International Journal of Cancer, 1999
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987